国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
15期
2381-2383
,共3页
ABO溶血病%新生儿%坏死性小肠结肠炎%静脉用丙种球蛋白%关系%研究
ABO溶血病%新生兒%壞死性小腸結腸炎%靜脈用丙種毬蛋白%關繫%研究
ABO용혈병%신생인%배사성소장결장염%정맥용병충구단백%관계%연구
ABO hemolytic disease%Newborn%Necrotizing enterocolitis%Intravenous immunoglobulin%Association%Research
目的 采取措施对患有严重ABO溶血病的新生儿,静脉输注大剂量的丙种球蛋白与坏死性小肠结肠炎(NEC)发病的关系进行有效性研究.方法 从医院收治的新生儿ABO溶血病患者中选取100例,其中男58例,女42例,他们的年龄在1个月至1岁之间.按照数字表的形式随机将这些患者划分成对照组与观察组,每一组有50例患者.对于对照组主要采取常规性治疗的方法.而对于观察组主要在常规性治疗的基础上给予大剂量的丙种球蛋白(IVIG)治疗.利用统计学理论对两组患者的临床疗效与静脉输注大剂量的丙种球蛋白与坏死性小肠结肠炎的关系进行系统性研究.(P<0.05).结果 经过一段时间的治疗与护理,观察组患者在治疗前血红总胆红素水平较高的状态,黄疸消退的时间少于对照组患者.而观察组中有10例被诊断为坏死性小肠结肠炎,对照组中有2例被诊断为坏死性小肠结肠炎.经过手术与药物治疗,有1例患儿死于大面积的小肠坏死,2例死于短肠综合征.结论 新生儿ABO溶血病静脉用大剂量丙种球蛋白与坏死性小肠结肠炎具有一定的相关性,但丙种球蛋白治疗新生儿ABO溶血病具有良好的临床疗效.
目的 採取措施對患有嚴重ABO溶血病的新生兒,靜脈輸註大劑量的丙種毬蛋白與壞死性小腸結腸炎(NEC)髮病的關繫進行有效性研究.方法 從醫院收治的新生兒ABO溶血病患者中選取100例,其中男58例,女42例,他們的年齡在1箇月至1歲之間.按照數字錶的形式隨機將這些患者劃分成對照組與觀察組,每一組有50例患者.對于對照組主要採取常規性治療的方法.而對于觀察組主要在常規性治療的基礎上給予大劑量的丙種毬蛋白(IVIG)治療.利用統計學理論對兩組患者的臨床療效與靜脈輸註大劑量的丙種毬蛋白與壞死性小腸結腸炎的關繫進行繫統性研究.(P<0.05).結果 經過一段時間的治療與護理,觀察組患者在治療前血紅總膽紅素水平較高的狀態,黃疸消退的時間少于對照組患者.而觀察組中有10例被診斷為壞死性小腸結腸炎,對照組中有2例被診斷為壞死性小腸結腸炎.經過手術與藥物治療,有1例患兒死于大麵積的小腸壞死,2例死于短腸綜閤徵.結論 新生兒ABO溶血病靜脈用大劑量丙種毬蛋白與壞死性小腸結腸炎具有一定的相關性,但丙種毬蛋白治療新生兒ABO溶血病具有良好的臨床療效.
목적 채취조시대환유엄중ABO용혈병적신생인,정맥수주대제량적병충구단백여배사성소장결장염(NEC)발병적관계진행유효성연구.방법 종의원수치적신생인ABO용혈병환자중선취100례,기중남58례,녀42례,타문적년령재1개월지1세지간.안조수자표적형식수궤장저사환자화분성대조조여관찰조,매일조유50례환자.대우대조조주요채취상규성치료적방법.이대우관찰조주요재상규성치료적기출상급여대제량적병충구단백(IVIG)치료.이용통계학이론대량조환자적림상료효여정맥수주대제량적병충구단백여배사성소장결장염적관계진행계통성연구.(P<0.05).결과 경과일단시간적치료여호리,관찰조환자재치료전혈홍총담홍소수평교고적상태,황달소퇴적시간소우대조조환자.이관찰조중유10례피진단위배사성소장결장염,대조조중유2례피진단위배사성소장결장염.경과수술여약물치료,유1례환인사우대면적적소장배사,2례사우단장종합정.결론 신생인ABO용혈병정맥용대제량병충구단백여배사성소장결장염구유일정적상관성,단병충구단백치료신생인ABO용혈병구유량호적림상료효.
Objective To explore the association of high-dose intravenous gamma globulin with necrotizing enterdcolitis in the treatment of ABO hemolytic disease of the newborn.Methods 100 cases of ABO hemolytic disease of the newborn who had been treated in our hospital were selected.58 were male and 42 were female and they aged between one month to one year.According to the digital form,the infants were randomly divided into a control group and a study group,50 for each group.The control group received routine treatment; while the study group received high-dose intravenous gamma globulin in addition to routine treatment.The clinical efficacy of the therapy and the association of high-dose intravenous gamma globulin with necrotizing enterocolitis were anaalyzed by using statistical theory.Results After a period of treatment and nursing,the total bilirubin level was at higher baseline level in the study group,and time to jaundice disappearance was shorter in the study group than in the control group.Necrotizing enterocolitis was diagnosed in 10 infants in the study group and in 2 in the control group.After surgical and medical treatment,one infant died of severe intestinal necrosis and 2 died of short bowel syndrome.Conclusions Intravenous high-dose gamma globulin has certain association with necrotizing enterocolitis in the treatment of ABO hemolytic disease of the newborn; however,it has a better clinical efficacy.